Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Evidence for Modulation of Oxygen Rebound Rate in Control of Outcome by Iron(II)- And 2-Oxoglutarate-Dependent Oxygenases

  • Juan Pan
  • , Eliott S. Wenger
  • , Megan L. Matthews
  • , Christopher J. Pollock
  • , Minakshi Bhardwaj
  • , Amelia J. Kim
  • , Benjamin D. Allen
  • , Robert B. Grossman
  • , Carsten Krebs
  • , J. Martin Bollinger

Producción científica: Articlerevisión exhaustiva

46 Citas (SciVal)

Resumen

Iron(II)- and 2-oxoglutarate-dependent (Fe/2OG) oxygenases generate iron(IV)-oxo (ferryl) intermediates that can abstract hydrogen from aliphatic carbons (R-H). Hydroxylation proceeds by coupling of the resultant substrate radical (R•) and oxygen of the Fe(III)-OH complex ("oxygen rebound"). Nonhydroxylation outcomes result from different fates of the Fe(III)-OH/R•state; for example, halogenation results from R•coupling to a halogen ligand cis to the hydroxide. We previously suggested that halogenases control substrate-cofactor disposition to disfavor oxygen rebound and permit halogen coupling to prevail. Here, we explored the general implication that, when a ferryl intermediate can ambiguously target two substrate carbons for different outcomes, rebound to the site capable of the alternative outcome should be slower than to the adjacent, solely hydroxylated site. We evaluated this prediction for (i) the halogenase SyrB2, which exclusively hydroxylates C5 of norvaline appended to its carrier protein but can either chlorinate or hydroxylate C4 and (ii) two bifunctional enzymes that normally hydroxylate one carbon before coupling that oxygen to a second carbon (producing an oxacycle) but can, upon encountering deuterium at the first site, hydroxylate the second site instead. In all three cases, substrate hydroxylation incorporates a greater fraction of solvent-derived oxygen at the site that can also undergo the alternative outcome than at the other site, most likely reflecting an increased exchange of the initially O2-derived oxygen ligand in the longer-lived Fe(III)-OH/R•states. Suppression of rebound may thus be generally important for nonhydroxylation outcomes by these enzymes.

Idioma originalEnglish
Páginas (desde-hasta)15153-15165
Número de páginas13
PublicaciónJournal of the American Chemical Society
Volumen141
N.º38
DOI
EstadoPublished - sept 25 2019

Nota bibliográfica

Publisher Copyright:
© 2019 American Chemical Society.

Financiación

This work was supported by the National Institutes of Health (GM113389 to C.J.P., GM113106 to J.M.B. and C.K., and GM127079 to C.K.). We thank Prof. Hung-wen Liu and Dr. Richiro Ushimaru for supplying the deuterated and hydroxylated hyoscyamine compounds and Dr. Jeffrey W. Slater for technical assistance. We dedicate this study to Larry Que, a pioneer in the field of nonheme iron chemistry, on the occasion of his 70th birthday.

FinanciadoresNúmero del financiador
National Institutes of Health (NIH)GM113106, GM113389
National Institute of General Medical Sciences DP2GM119177 Sophie Dumont National Institute of General Medical SciencesR35GM127079

    ASJC Scopus subject areas

    • Catalysis
    • Biochemistry
    • General Chemistry
    • Colloid and Surface Chemistry

    Huella

    Profundice en los temas de investigación de 'Evidence for Modulation of Oxygen Rebound Rate in Control of Outcome by Iron(II)- And 2-Oxoglutarate-Dependent Oxygenases'. En conjunto forman una huella única.

    Citar esto